NYSE · CTEV
Healthcare · Medical - Healthcare Information Services
$35.54
Down-$0.90 (-2.47%)
Updated Sep 16, 2026, 4:21 AM
SID Score
6.3/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
CTEV closed at $35.54 after 20 trading sessions, down 0.17% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $36.08 | $36.465 | $34.19 | $35.54 | 116.36K |
| Sep 14, 2026 | $35.66 | $37.28 | $35.66 | $36.44 | 126.87K |
| Sep 11, 2026 | $37.23 | $37.57 | $33.87 | $35.98 | 153.68K |
| Sep 10, 2026 | $35.35 | $37.77 | $35.2279 | $36.74 | 82.88K |
| Sep 9, 2026 | $37.71 | $37.71 | $35.655 | $36.29 | 119.2K |
| Sep 8, 2026 | $37.77 | $38.5806 | $36.41 | $37.71 | 94.93K |
| Sep 4, 2026 | $39.08 | $39.08 | $37.66 | $38.43 | 70.57K |
| Sep 3, 2026 | $40.46 | $42.00 | $38.52 | $39.09 | 83.85K |
| Sep 2, 2026 | $38.86 | $40.29 | $36.99 | $40.23 | 117.65K |
| Sep 1, 2026 | $39.43 | $40.82 | $38.83 | $39.35 | 134.83K |
| Aug 31, 2026 | $41.05 | $41.68 | $38.9562 | $39.83 | 139.41K |
| Aug 28, 2026 | $38.06 | $39.6463 | $37.85 | $39.39 | 132.98K |
| Aug 27, 2026 | $37.47 | $39.79 | $37.47 | $38.78 | 155.27K |
| Aug 26, 2026 | $37.58 | $37.63 | $36.855 | $37.57 | 63.91K |
| Aug 25, 2026 | $36.64 | $38.85 | $35.68 | $37.64 | 139.86K |
| Aug 24, 2026 | $37.53 | $38.3982 | $36.29 | $36.58 | 76.19K |
| Aug 21, 2026 | $34.25 | $37.34 | $34.25 | $37.27 | 199.24K |
| Aug 20, 2026 | $35.00 | $35.00 | $33.9205 | $34.08 | 94.41K |
| Aug 19, 2026 | $36.11 | $37.21 | $35.18 | $35.39 | 102.07K |
| Aug 18, 2026 | $35.02 | $36.2364 | $34.58 | $35.60 | 107.22K |
The latest Smart Investors Daily articles mentioning CTEV.
CTEV research
Company profile and research snapshot.
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 21, 2026 | Barclays | Overweight | — |
| Aug 12, 2026 | Wells Fargo | Equal-Weight | — |
| Aug 10, 2026 | Citigroup | Buy | — |
| Aug 10, 2026 | Canaccord Genuity | Buy | — |
| Jul 21, 2026 | Canaccord Genuity | Buy | — |
No generated briefing is available yet.
Yahoo · Sep 8, 2026
On August 7, Claritev Corporation (NYSE:CTEV) reported second-quarter results that beat its own targets, marking five consecutive quarters of year-over-year revenue growth. Revenue for the quarter ended June 30 climbed 6.6% to $257.5 million, and management used the momentum to raise full-year guidance for the second time this year. The number that matters most, though, […]
Fintel · Aug 28, 2026
Yahoo · Aug 27, 2026
MCLEAN, Va., August 27, 2026--Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV), a healthcare technology, data, and insights company, today announced that members of its management team will meet with investors at the following events in September 2026:
Benzinga · Aug 21, 2026
Barclays analyst Glen Santangelo maintains Claritev (NYSE:CTEV) with a Overweight and raises the price target from $28 to $40.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CTEV.
